1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics,2009. CA Cancer J Clin 2009;59:225–249. PMID:
19474385.
2. National Cancer Information Center [Internet]. Goyang: National Cancer Information Center; c2012.cited 2013 Jan 26. Available from:
http://www.cancer.go.kr
3. Shin HR, Jung KW, Won YJ, Park JG. 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat 2004;36:103–114. PMID:
20396549.
4. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003;196:722–728. PMID:
12742204.
5. Makela J, Haukipuro K, Laitinen S, Kairaluoma MI. Palliative operations for colorectal cancer. Dis Colon Rectum 1990;33:846–850. PMID:
1698594.
6. Liu SK, Church JM, Lavery IC, Fazio VW. Operation in patients with incurable colon cancer--is it worthwhile? Dis Colon Rectum 1997;40:11–14. PMID:
9102251.
7. Beham A, Rentsch M, Pullmann K, Mantouvalou L, Spatz H, Schlitt HJ, et al. Survival benefit in patients after palliative resection vs non-resection colon cancer surgery. World J Gastroenterol 2006;12:6634–6638. PMID:
17075976.
8. Costi R, Mazzeo A, Di Mauro D, Veronesi L, Sansebastiano G, Violi V, et al. Palliative resection of colorectal cancer: does it prolong survival? Ann Surg Oncol 2007;14:2567–2576. PMID:
17541693.
9. Kleespies A, Fuessl KE, Seeliger H, Eichhorn ME, Muller MH, Rentsch M, et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis 2009;24:1097–1109. PMID:
19495779.
10. Yun HR, Lee WY, Lee WS, Cho YB, Yun SH, Chun HK. The prognostic factors of stage IV colorectal cancer and assessment of proper treatment according to the patient's status. Int J Colorectal Dis 2007;22:1301–1310. PMID:
17486358.
11. Cunningham D, Pyrhonen S, James RD, Punt CJ, Hickish TF, Heikkila R, et al. Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer. Lancet 1998;352:1413–1418. PMID:
9807987.
12. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938–2947. PMID:
10944126.
13. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350:2335–2342. PMID:
15175435.
14. Zacharakis M, Xynos ID, Lazaris A, Smaro T, Kosmas C, Dokou A, et al. Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res 2010;30:653–660. PMID:
20332485.
15. Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005;89:211–217. PMID:
15726622.
16. Kim JH, Shon DH, Cahng BI, Chung MK, Shim MC. Complete single stage management of left colon cancer obstruction with a new devices. J Korean Soc Coloproctol 2002;18:30–36.
17. Kim SK, Lee CH, Lee MR, Kim JH. Multivariate analysis of the survival rate for treatment modalities in incurable stage IV colorectal cancer. J Korean Soc Coloproctol 2012;28:35–41. PMID:
22413080.
18. Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med 1990;113:779–788. PMID:
2240880.
19. Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H, et al. Comparison of 17,641 patients with right- and left-sided colon cancer: differences in epidemiology, perioperative course, histology, and survival. Dis Colon Rectum 2010;53:57–64. PMID:
20010352.
20. Hansen IO, Jess P. Possible better long-term survival in left versus right-sided colon cancer: a systematic review. Dan Med J 2012;59:A4444PMID:
22677242.